Executive Interview: ROI or Bust - Why Emotions No Longer Cut It in Healthcare

Why It Matters

Because ROI‑focused AI governance forces healthcare organizations to prove financial and clinical value, aligning technology spend with patient outcomes and protecting against costly security failures.

Key Takeaways

• ROI now mandatory for AI projects, emotions insufficient
• Governance must balance readiness and control for AI implementations
• Hard ROI metrics preferred; soft metrics still valuable but harder
• Post‑implementation accountability ensures measured outcomes and credibility across teams
• Cyber‑security risks rise as AI and cloud dependencies increase

Summary

The interview with CDW’s Eli Tarlo spotlights a decisive shift in healthcare technology: AI initiatives must now be justified with concrete return‑on‑investment (ROI) rather than relying on enthusiasm or fear of falling behind. Tarlo argues that the era of “shiny‑toy” AI hype is over; executives are demanding business cases that quantify clinical, operational, and financial gains before green‑lighting projects.

Key insights include the emergence of hard‑metric ROI expectations, the critical role of governance in distinguishing readiness from throttling, and the need for post‑implementation accountability to close the loop on promised benefits. Tarlo notes that many vendors are even offering profit‑share models, betting on their AI’s ability to deliver measurable dollars. He also emphasizes that ROI can be soft or hard, but hard numbers carry more weight in today’s budget‑constrained environment.

A memorable quote from the conversation captures the new mindset: “It’s not should we do it, it’s how can we not do it,” underscoring that AI is becoming a competitive necessity. Tarlo also warns that security lapses—such as premature patches or cloud‑service outages—can quickly erode trust, especially as AI amplifies attackers’ capabilities.

The implications are clear: healthcare leaders must embed ROI analysis, rigorous governance, and continuous performance tracking into every AI rollout. Failure to do so risks wasted spend, regulatory scrutiny, and heightened cyber‑risk, while successful ROI‑driven AI can drive better patient outcomes, operational efficiency, and a stronger competitive position.

Original Description

Live from HIMSS 2026, Drex DeFord sits down with Eli Tarlow, Director of Industry Strategists at CDW, for a candid conversation about the state of AI in healthcare. Eli breaks down the evolution from AI curiosity to AI accountability, where gut feelings have been replaced by hard business plans, measurable ROI, and a closing-the-loop mentality that puts operational leaders on the hook for results.

Key Points:

01:44 AI Maturity Shift

03:05 Proving ROI With AI

06:05 Accountability and Budget Math

09:19 Resiliency and Cloud DR

Linkedin: https://www.linkedin.com/company/ThisWeekHealth

Twitter: https://twitter.com/thisweekhealth

Donate: Alex’s Lemonade Stand: Foundation for Childhood Cancer - https://www.alexslemonade.org/mypage/3173454